JP7430172B2 - 腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物 - Google Patents
腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物 Download PDFInfo
- Publication number
- JP7430172B2 JP7430172B2 JP2021504123A JP2021504123A JP7430172B2 JP 7430172 B2 JP7430172 B2 JP 7430172B2 JP 2021504123 A JP2021504123 A JP 2021504123A JP 2021504123 A JP2021504123 A JP 2021504123A JP 7430172 B2 JP7430172 B2 JP 7430172B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- extract
- daikenchuto
- intestinal flora
- faecalibacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 64
- 230000000968 intestinal effect Effects 0.000 title claims description 32
- 241001608234 Faecalibacterium Species 0.000 title claims description 22
- 239000000284 extract Substances 0.000 claims description 46
- 239000009372 dai-kenchu-to Substances 0.000 claims description 42
- 244000131415 Zanthoxylum piperitum Species 0.000 claims description 24
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 claims description 24
- 235000013305 food Nutrition 0.000 claims description 24
- 241000208340 Araliaceae Species 0.000 claims description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 15
- 235000008434 ginseng Nutrition 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 10
- 235000008397 ginger Nutrition 0.000 claims description 10
- 241000411851 herbal medicine Species 0.000 claims description 9
- 230000002265 prevention Effects 0.000 claims description 6
- 208000006673 asthma Diseases 0.000 claims description 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 description 19
- 239000003814 drug Substances 0.000 description 17
- 208000024891 symptom Diseases 0.000 description 10
- 241000234314 Zingiber Species 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 8
- 230000001668 ameliorated effect Effects 0.000 description 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 244000000626 Daucus carota Species 0.000 description 4
- 235000002767 Daucus carota Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 235000015110 jellies Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229960004559 theobromine Drugs 0.000 description 4
- 208000011231 Crohn disease Diseases 0.000 description 3
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 3
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 235000001046 cacaotero Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 206010071061 Small intestinal bacterial overgrowth Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000008991 intestinal motility Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000007142 small intestinal bacterial overgrowth Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000605980 Faecalibacterium prausnitzii Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 206010052402 Gastrointestinal hypermotility Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 235000005769 Japanese ginseng Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000003174 Panax japonicus Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 241000186569 [Clostridium] leptum Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 239000000795 chinese herbal drug Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- -1 etc. Chemical compound 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000018936 intestinal hypermotility Diseases 0.000 description 1
- 230000037036 intestinal hypermotility Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000003289 regulatory T cell Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/145—Clostridium
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
項2.腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるために有効な1日分の摂取量の大建中湯エキスを含む、項1に記載の組成物。
項3.1日分の摂取量が0.1~15 gとなる量で大建中湯エキスを含む、項1又は2に記載の組成物。
項4.1日分の摂取量が0.1~3.0 gとなる量で大建中湯エキスを含む、項1又は2に記載の組成物。
項5.前記大建中湯エキスを得るための原料生薬の質量比が、山椒又は花椒1に対し、人参0.2~2.0、乾姜1.0~3.0である、項1~4のいずれか一項に記載の組成物。
項6.前記大建中湯エキスを得るための原料生薬の質量比が、山椒又は花椒1に対し、人参0.4~1.4、乾姜1.4~2.4である、項1~4のいずれか一項に記載の組成物。
項7.腸内菌叢中のフィーカリバクテリウム属菌の占有率増加により治療、予防若しくは改善しうる疾患又は症状の治療、予防若しくは改善に用いられる、項1~6のいずれか一項に記載の組成物。
項8.食品である、項1~7のいずれか一項に記載の組成物。
項9.腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させる方法であって、大建中湯エキスを含む組成物を、それを必要とする哺乳動物に投与する工程を含む、方法。
項10.腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物の製造における大建中湯エキスの使用。
項11.前記組成物が、腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるために有効な1日分の摂取量の大建中湯エキスを含む、項9に記載の方法、又は、項10に記載の使用。
項12.前記組成物が、1日分の摂取量が0.1~15 gとなる量で大建中湯エキスを含む、項9もしくは11に記載の方法、又は、項10もしくは11に記載の使用。
項13.前記組成物が、1日分の摂取量が0.1~3.0 gとなる量で大建中湯エキスを含む、項9もしくは11に記載の方法、又は、項10もしくは11に記載の使用。
項14.前記大建中湯エキスを得るための原料生薬の質量比が、山椒又は花椒1に対し、人参0.2~2.0、乾姜1.0~3.0である、項9及び11~13のいずれか一項に記載の方法、又は、項10~13のいずれか一項に記載の使用。
項15.前記大建中湯エキスを得るための原料生薬の質量比が、山椒又は花椒1に対し、人参0.4~1.4、乾姜1.4~2.4である、項9及び11~13のいずれか一項に記載の方法、又は、項10~13のいずれか一項に記載の使用。
項16.前記組成物が食品である、項9及び11~15のいずれか一項に記載の方法、又は、項10~15のいずれか一項に記載の使用。
項17.腸内菌叢中のフィーカリバクテリウム属菌の占有率増加により治療、予防若しくは改善しうる疾患又は症状の治療、予防若しくは改善方法である、項9及び11~16のいずれか一項に記載の方法。
項18.前記組成物が、腸内菌叢中のフィーカリバクテリウム属菌の占有率増加により治療、予防若しくは改善しうる疾患又は症状の治療、予防若しくは改善に用いられる、項10~16のいずれか一項に記載の使用。
組成物の作製
市販される花椒、御種人参、乾姜を、質量比1:1:2で含めて公知の手法にて大建中湯エキスを抽出した。得られたエキス1.25 g、水飴2.6 g、エタノール0.085 g、精製水0.565 gを混ぜて、4.5 gとし、1日分の組成物とした。
20歳以上60歳未満の健康な被験者5人をスクリーニングにより選抜して、組成物の摂取は1~7日の就寝前に行った。組成物摂取時、水あるいは湯などを同時に摂取してもよいこととした。また、菌叢の占有率の計測を組成物摂取前日(0日目)と摂取7日後の次の日の朝(8日目)に行った。
被験者には、試験期間中は通常通りの生活を送らせるとともに、次の制限事項を遵守するよう指導した。
・食事は、これまでの食生活(食事量、食事内容)を大きく変えず、日常範囲を大きく逸脱する過度な節食及び過食は控える。
・アルコールの摂取は、原則として制限しないが、これまでのアルコール摂取の程度を大きく変えることは控える。
・摂取1週後の採便が終了するまで、大きな生活の変化は、可能な限り控える。
糞便中のDNAを精製し、16S rRNA V1-V2領域を増幅し、次世代シーケンサーMiSeq (イルミナ)を用いて配列解析を行った。クオリティーフィルタリング後、各検体についてランダムに10,000リードを選び、97%の相同性でクラスタリングした後、OTU (operational taxonomic unit)に分類した。形成されたOTUの代表配列を完全長16S遺伝子データベースに対して照合し、菌種の特定及び構成の解析を行った。クラスタリングから菌叢組成解析は、QIIMEのパイプラインを用い、完全長16S遺伝子データベースはGeengenesを利用した。
QIIME:Nat Methods. 2010 May;7(5):335-6. doi: 10.1038/nmeth.f.303. Epub 2010 Apr 11.
Geengenes:Applied and Environmental Microbiology, July 2006, Vol.72, No.7, p.5069-5072, DOI: 10.1128/AEM.03006-05
結果を表1及び図1に示す。被験者腸内菌叢(属レベル)では、腸内菌叢全菌数を100%とした場合のフィーカリバクテリウム属菌の占有率が、試験食品摂取群において、摂取前(0日目)と比較して摂取後(8日目)で5人中4人が2%以上増加した(表1、図1)。
Claims (7)
- 大建中湯エキスを含む、腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物であって、前記大建中湯エキスを得るための原料生薬の質量比が、山椒又は花椒1に対し、人参0.2~2.0、乾姜1.0~3.0である、組成物。
- 腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるために有効な1日分の摂取量の大建中湯エキスを含む、請求項1に記載の組成物。
- 1日分の摂取量が0.1~15 gとなる量で大建中湯エキスを含む、請求項1又は2に記載の組成物。
- 1日分の摂取量が0.1~3.0 gとなる量で大建中湯エキスを含む、請求項1又は2に記載の組成物。
- 前記大建中湯エキスを得るための原料生薬の質量比が、山椒又は花椒1に対し、人参0.4~1.4、乾姜1.4~2.4である、請求項1~4のいずれか一項に記載の組成物。
- 非アルコール性脂肪性肝炎、2型糖尿病、又は喘息の治療、予防若しくは改善に用いられる、請求項1~5のいずれか一項に記載の組成物。
- 食品である、請求項1~6のいずれか一項に記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019039870 | 2019-03-05 | ||
JP2019039870 | 2019-03-05 | ||
PCT/JP2020/009067 WO2020179810A1 (ja) | 2019-03-05 | 2020-03-04 | 腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2020179810A1 JPWO2020179810A1 (ja) | 2020-09-10 |
JP7430172B2 true JP7430172B2 (ja) | 2024-02-09 |
Family
ID=72338125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021504123A Active JP7430172B2 (ja) | 2019-03-05 | 2020-03-04 | 腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220062362A1 (ja) |
JP (1) | JP7430172B2 (ja) |
KR (1) | KR20210135540A (ja) |
CN (1) | CN113507959A (ja) |
TW (1) | TWI824117B (ja) |
WO (1) | WO2020179810A1 (ja) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8623914B2 (en) * | 2011-02-10 | 2014-01-07 | Tsumura & Co. | Medical composition |
CN104415027A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 大蒜素在调节动物肠道菌群中的用途 |
CN105796483A (zh) * | 2014-12-29 | 2016-07-27 | 四川滇虹医药开发有限公司 | 一种中药口服液及其制备方法 |
JP2017175999A (ja) * | 2016-03-29 | 2017-10-05 | 株式会社ツムラ | 大建中湯の効果予測方法および投与量決定方法 |
JP7467804B2 (ja) | 2016-09-21 | 2024-04-16 | 株式会社明治 | 腸内菌叢改善用組成物 |
CN107875370B (zh) * | 2017-12-19 | 2020-12-29 | 深圳健安医药有限公司 | 用于促进肠蠕动排气防止肠粘连的中药组合物及制备方法 |
-
2020
- 2020-03-04 CN CN202080018469.1A patent/CN113507959A/zh active Pending
- 2020-03-04 JP JP2021504123A patent/JP7430172B2/ja active Active
- 2020-03-04 TW TW109107145A patent/TWI824117B/zh active
- 2020-03-04 WO PCT/JP2020/009067 patent/WO2020179810A1/ja active Application Filing
- 2020-03-04 US US17/435,568 patent/US20220062362A1/en active Pending
- 2020-03-04 KR KR1020217031309A patent/KR20210135540A/ko unknown
Non-Patent Citations (4)
Title |
---|
Gastroenterology,2017年,Vol. 152, No. 5, Suppl. 1,p.S969 |
Pharmacology research & perspectives,2016年,Vol. 4,No.1,pp.1-10 |
PLOS ONE,2014年,Vol. 9, No. 12,pp.1-19 |
The Journal of Medical Investigation,2013年,Vol.60,No.3-4,pp.221-227 |
Also Published As
Publication number | Publication date |
---|---|
KR20210135540A (ko) | 2021-11-15 |
CN113507959A (zh) | 2021-10-15 |
JPWO2020179810A1 (ja) | 2020-09-10 |
WO2020179810A1 (ja) | 2020-09-10 |
US20220062362A1 (en) | 2022-03-03 |
TWI824117B (zh) | 2023-12-01 |
TW202100176A (zh) | 2021-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2763172C2 (ru) | Применение молочнокислых бактерий для лечения или предупреждения по меньшей мере одного состояния из числа послеродовой депрессии и послеродовой тревожности | |
JP6815410B2 (ja) | 気分プロフィール改善剤 | |
EP1946760A1 (en) | Composition for improving intestinal flora | |
JP7280069B2 (ja) | 機能性消化管障害予防又は改善用組成物、並びに、該機能性消化管障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物 | |
EP3777869B1 (en) | Sleep-promoting composition, and medicinal composition and food and beverage composition using said sleep-promoting composition | |
WO2017130859A1 (ja) | 神経細胞死抑制剤 | |
JP2019112328A (ja) | 概日リズム改善用組成物 | |
JP2024026804A (ja) | 疲労感、意欲低下または眠気の改善剤 | |
JP2023014246A (ja) | 認知機能改善剤、認知機能維持剤、海馬機能改善剤及び海馬機能維持剤 | |
JP6976030B2 (ja) | 非アルコール性脂肪肝疾患の予防または改善用組成物 | |
JP7467804B2 (ja) | 腸内菌叢改善用組成物 | |
JP7430172B2 (ja) | 腸内菌叢中のフィーカリバクテリウム属菌の占有率を増加させるための組成物 | |
EP4166152A1 (en) | Composition for suppressing or improving depression | |
JP6173850B2 (ja) | 筋肉増量剤、運動併用時の筋肉増量剤、及び筋肉増量用の飲食品 | |
JP7072966B2 (ja) | 機能性身体症候群の予防又は改善用剤及びそれを含む組成物 | |
WO2023176952A1 (ja) | 腸管内での細菌の増殖制御用組成物及びその利用 | |
JP2023096870A (ja) | アッカーマンシア属細菌の増殖促進剤 | |
JP2013201968A (ja) | ラクトバチルス・アシドフィラス含有飲食品 | |
WO2022045138A1 (ja) | 腸内菌叢中の特定の細菌属の占有率を変化させるための組成物 | |
JP2022079610A (ja) | 血中中性脂肪上昇抑制組成物 | |
JP2024121164A (ja) | 気分状態改善用組成物 | |
CN118119286A (zh) | 用于促进低聚糖的同化的组合物 | |
JP2019187264A (ja) | 糖代謝異常の予防および改善用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231127 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240109 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240130 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7430172 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |